Skip to main content
    A

    AstraZeneca PLC (AZN)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE

    $184.45
    +0.07 (+0.04%)

    Market Cap: $286.07B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    AstraZeneca PLC (AZN) Government Contracts

    Updated Aug 4, 2026. Contract data from federal award records.

    Federal agencies obligated $733,852 to AstraZeneca over the 12 months through Jul 31, 2026. That is less than 1% of its revenue. Department of Veterans Affairs was the top awarding agency with 99.9% of obligations across 2 agencies.

    Federal Obligations

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated.

    Obligations
    $733,852
    Obligations to revenue
    0.0%
    Prior 12 months-$23.83M
    Contracts with activity4
    New contracts3
    Top agencyDepartment of Veterans Affairs
    Top agency share99.9%
    Agencies2
    Average remaining term4.6 months

    12 months through Jul 31, 2026

    Largest New Awards

    The 3 largest new awards total $1.36M, and the largest makes up 92.6% of that.

    Award IDAgencyRecipientAmountStartEndDescription
    36C26026F0055Department of Veterans Affairs, Department of Veterans AffairsALEXION PHARMACEUTICALS INC$1.26MDec 22, 2025Dec 21, 2026STRENSIQ 80 MG/0.8 ML INJ.
    36C24526N0739Department of Veterans Affairs, Department of Veterans AffairsALEXION PHARMACEUTICALS INC$104,650Jul 21, 2026Jul 23, 2026STRENSIQ 80 MG
    SPE2D026F0023Department of Defense, Defense Logistics AgencyASTRAZENECA PHARMACEUTICALS LP$500Nov 3, 2025Nov 16, 20268511731821!OTHER MEDICAL
    New federal contracts awarded in the 12 months through Jul 31, 2026, largest first.

    Monthly Obligations

    The latest complete month, Apr 2026, had net de-obligations of $626,807. The largest month in the table was Oct 2025, at $1.25M.

    MonthObligations
    Jul 2026$104,650
    Jun 2026$0
    May 2026$0
    Apr 2026-$626,807
    Mar 2026$0
    Feb 2026$2,191
    Jan 2026$0
    Dec 2025$0
    Nov 2025$500
    Oct 2025$1.25M
    Sep 2025$0
    Aug 2025-$297
    MonthObligations
    Jul 2025$0
    Jun 2025$0
    May 2025-$731,482
    Apr 2025-$20,322
    Mar 2025$39,959
    Feb 2025$0
    Jan 2025$0
    Dec 2024-$23.12M
    Nov 2024$0
    Oct 2024$500
    Sep 2024$0
    Aug 2024$0

    Net obligations recorded each month, newest first. Agencies report contract actions with a delay (the Defense Department about 90 days), so the latest months, May to Jul 2026, are still incomplete and the 12-month total usually rises as agencies report the rest.

    Frequently Asked Questions About AZN

    How much does AstraZeneca receive in federal contracts?

    AstraZeneca had $733,852 in federal contract obligations over the 12 months through Jul 31, 2026, compared with -$23.83M in the 12 months before. Obligations are contract bookings by the awarding agency, not recognized revenue.

    What are AstraZeneca's largest government contracts?

    The largest new awards over the 12 months through Jul 31, 2026 were 36C26026F0055, Department of Veterans Affairs, $1.26M, started Dec 22, 2025; 36C24526N0739, Department of Veterans Affairs, $104,650, started Jul 21, 2026; SPE2D026F0023, Department of Defense, $500, started Nov 3, 2025.

    Which agencies award AstraZeneca contracts?

    Department of Veterans Affairs was the top awarding agency with 99.9% of obligations over the 12 months through Jul 31, 2026. The records cover 2 agencies. Other agencies in the awards list include Department of Defense.

    What new federal contracts did AstraZeneca win in the 12 months through Jul 31, 2026?

    AstraZeneca won 3 new federal contracts in the 12 months through Jul 31, 2026. The largest was 36C26026F0055, Department of Veterans Affairs, $1.26M, started Dec 22, 2025.

    How do AstraZeneca's federal obligations compare with its revenue?

    Federal contract obligations were $733,852 over the 12 months through Jul 31, 2026, equivalent to less than 1% of AstraZeneca's revenue. Obligations are amounts the government committed to contracts in the period, not the share of AstraZeneca's revenue that comes from the government.